Buscar resultados de ensayos clínicos
Inclusion Body Myositis - 28 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Arimoclomol in Sporadic Inclusion Body Myositis Condición: Inclusion Body Myositis Fecha: 2008-10-08 Intervenciones:
|
Completed |
Nombre del estudio: Efficacy, Safety and Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis Condición: Sporadic Inclusion Body Myositis Fecha: 2011-08-12 Intervenciones:
|
Completed |
Nombre del estudio: Study of Long-term Safety, Efficacy Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis Condición: Sporadic Inclusion Body Myositis (sIBM) Fecha: 2014-03-20 Intervenciones: Drug: BYM338 (Bimagrumab) |
Completed |
Nombre del estudio: Lithium in Inclusion Body Myositis (IBM) Condición: Inclusion Body Myositis Fecha: 2009-06-08 |
Not yet recruiting |
Nombre del estudio: Study of Arimoclomol in Inclusion Body Myositis (IBM) Condición: Inclusion Body Myositis Fecha: 2016-04-25 Intervenciones:
|
Completed |
Nombre del estudio: Muscle Strength and Inflammatory Response in Patients With Inclusion Body Myositis Condición: Inclusion Body Myositis Fecha: 2009-05-11 |
Completed |
Nombre del estudio: Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis Condición: Inclusion Body Myositis Fecha: 2008-12-04 Intervenciones: Drug: Etanercept 50 milligrams subcutaneously every week |
Active, not recruiting |
Nombre del estudio: An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203 Condición: Sporadic Inclusion Body Myositis Fecha: 2015-07-09 Intervenciones:
|
Completed |
Nombre del estudio: Blood-flow Restricted Exercise in Inclusion Body Myositis Condición: Sporadic Inclusion Body Myositis Fecha: 2014-12-10 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Natalizumab in Inclusion Body Myositis (IBM) Condición: Inclusion Body Myositis (IBM) Fecha: 2013-05-31 Intervenciones: Drug: Natalizumab Other Name: Tysabri |